| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H21NO5 |
| Molecular Weight | 367.3951 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CC2=C3OCOC3=CC=C2[C@@]4(C)[C@@H](O)CC5=CC6=C(OCO6)C=C5[C@@H]14
InChI
InChIKey=IQUGPRHKZNCHGC-TYPHKJRUSA-N
InChI=1S/C21H21NO5/c1-21-14-3-4-15-19(27-10-24-15)13(14)8-22(2)20(21)12-7-17-16(25-9-26-17)5-11(12)6-18(21)23/h3-5,7,18,20,23H,6,8-10H2,1-2H3/t18-,20+,21-/m0/s1
| Molecular Formula | C21H21NO5 |
| Molecular Weight | 367.3951 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 72.4 µM [IC50] |